Indo Us Bio-Tech Limited (BOM:541304)
India · Delayed Price · Currency is INR 85.04
-1.02 (-1.19%)
At close: Aug 21, 2026
Indo Us Bio-Tech Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 1,127 | 1,104 | 1,038 | 728.36 | 617.45 | 500.59 |
| 1,127 | 1,104 | 1,038 | 728.36 | 617.45 | 500.59 | |
Revenue Growth | 2.52% | 6.36% | 42.56% | 17.96% | 23.34% | 24.80% |
Cost of Revenue | 841.74 | 802.7 | 698.44 | 466.39 | 433.94 | 343.51 |
Gross Profit | 284.82 | 301.69 | 339.95 | 261.97 | 183.5 | 157.08 |
Selling, General & Admin | 14.3 | 14.21 | 39.74 | 39.67 | 31.48 | 25.53 |
Other Operating Expenses | 113.73 | 116.82 | 109.73 | 111.64 | 58.05 | 62.09 |
Operating Expenses | 137.73 | 140.05 | 160.45 | 159.32 | 97.79 | 92.09 |
Operating Income | 147.09 | 161.64 | 179.49 | 102.66 | 85.71 | 64.99 |
Interest Expense | -25.32 | -22.43 | -14.36 | -14.1 | -11.24 | -11.45 |
Interest & Investment Income | - | - | 0.7 | 0.12 | - | 0.03 |
Other Non Operating Income (Expenses) | - | - | -0.52 | -0.7 | -0.6 | -0.46 |
EBT Excluding Unusual Items | 121.77 | 139.2 | 165.31 | 87.98 | 73.87 | 53.11 |
Gain (Loss) on Sale of Assets | - | - | - | -0.04 | - | - |
Pretax Income | 121.77 | 139.2 | 165.31 | 87.94 | 73.87 | 53.11 |
Income Tax Expense | 7.19 | 7.97 | 2.63 | 5.53 | 1.46 | 2.48 |
Net Income | 114.58 | 131.23 | 162.67 | 82.41 | 72.4 | 50.63 |
Net Income to Common | 114.58 | 131.23 | 162.67 | 82.41 | 72.4 | 50.63 |
Net Income Growth | -35.63% | -19.33% | 97.41% | 13.81% | 43.00% | 3.34% |
Shares Outstanding (Basic) | 20 | 20 | 20 | 20 | 19 | 12 |
Shares Outstanding (Diluted) | 20 | 20 | 20 | 20 | 19 | 12 |
Shares Change | 0.34% | 0.07% | - | 3.95% | 57.60% | -15.96% |
EPS (Basic) | 5.70 | 6.54 | 8.11 | 4.11 | 3.75 | 4.14 |
EPS (Diluted) | 5.70 | 6.54 | 8.11 | 4.11 | 3.75 | 4.13 |
EPS Growth | -35.86% | -19.38% | 97.41% | 9.49% | -9.22% | 22.97% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | -149.89 | 5.57 | -3.89 | -12.97 | -12.64 |
Free Cash Flow Per Share | - | -7.47 | 0.28 | -0.19 | -0.67 | -1.03 |
Dividend Per Share | - | - | 0.250 | - | - | 0.125 |
Dividend Growth | - | - | - | - | - | - |
Gross Margin | 25.28% | 27.32% | 32.74% | 35.97% | 29.72% | 31.38% |
Operating Margin | 13.06% | 14.64% | 17.29% | 14.09% | 13.88% | 12.98% |
Profit Margin | 10.17% | 11.88% | 15.67% | 11.31% | 11.73% | 10.12% |
Free Cash Flow Margin | - | -13.57% | 0.54% | -0.53% | -2.10% | -2.52% |
EBITDA | 155.62 | 170.66 | 190.47 | 110.66 | 93.97 | 69.45 |
EBITDA Margin | 13.81% | 15.45% | 18.34% | 15.19% | 15.22% | 13.87% |
D&A For EBITDA | 8.53 | 9.02 | 10.98 | 8 | 8.26 | 4.46 |
EBIT | 147.09 | 161.64 | 179.49 | 102.66 | 85.71 | 64.99 |
EBIT Margin | 13.06% | 14.64% | 17.29% | 14.09% | 13.88% | 12.98% |
Effective Tax Rate | 5.91% | 5.73% | 1.59% | 6.29% | 1.98% | 4.67% |
Revenue as Reported | 1,128 | 1,105 | 1,040 | 731.55 | 617.66 | 502.41 |
Advertising Expenses | - | - | 0.44 | 0.26 | 0.06 | 0.22 |